Prevalence and accessory gene regulator (agr) analysis of vancomycin-intermediate Staphylococcus aureus among methicillin-resistant isolates in Taiwan—SMART program, 2003
- 13 February 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 29 (4), 383-389
- https://doi.org/10.1007/s10096-009-0868-4
Abstract
The prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in nosocomial staphylococcal infections in Taiwan has exceeded 50% since 2000. However, little relevant data has been available concerning vancomycin-intermediate S. aureus (VISA) and heteroresistant VISA (hVISA). We collected 1,000 MRSA isolates from ten medical center hospitals in Taiwan during 2003. All were initially screened for reduced susceptibility to vancomycin on brain heart infusion (BHI) agar containing 5 mg/L vancomycin. Among 34 MRSA isolates that grew on the screening plates, two VISA isolates (0.2%) and seven hVISA isolates (0.7%) were evident. Vancomycin-resistant S. aureus was not detected. The accessory gene regulator (agr) typing of all 1,000 MRSA strains were typed by multiplex polymerase chain reaction (PCR); 919 strains (91.9%) including the VISA and hVISA isolates belonged to agr group I, 78 strains (7.8%) were agr group II, two strains (0.2%) were agr group III, and one isolate (0.1%) was agr group IV. There was no relationship between sample sites and agr typing. In 2003, the incidence of hVISA and VISA in Taiwan was low. Continued surveillance is recommended, given the implementation of new Clinical and Laboratory Standards Institute (CLSI) criteria for S. aureus and the increasing clinical use of glycopeptides.Keywords
This publication has 40 references indexed in Scilit:
- Increased Vancomycin MICs for Staphylococcus aureus Clinical Isolates from a University Hospital during a 5-Year PeriodJournal of Clinical Microbiology, 2006
- Inhibition of the Autolytic System by Vancomycin Causes Mimicry of Vancomycin-Intermediate Staphylococcus aureus -Type Resistance, Cell Concentration Dependence of the MIC, and Antibiotic Tolerance in Vancomycin-Susceptible S. aureusAntimicrobial Agents and Chemotherapy, 2006
- Septic Arthritis Caused by Vancomycin-Intermediate Staphylococcus aureusJournal of Clinical Microbiology, 2005
- Staphylococcus aureus Isolates with Reduced Susceptibility to Glycopeptides Belong to Accessory Gene Regulator Group I or IIAntimicrobial Agents and Chemotherapy, 2004
- Vancomycin Treatment Failure Associated with Heterogeneous Vancomycin-Intermediate Staphylococcus aureus in a Patient with Endocarditis and in the Rabbit Model of EndocarditisAntimicrobial Agents and Chemotherapy, 2003
- Bacterial Competition for Human Nasal Cavity Colonization: Role of Staphylococcal agr AllelesApplied and Environmental Microbiology, 2003
- Prevalence of agr Specificity Groups among Staphylococcus aureus Strains Colonizing Children and Their GuardiansJournal of Clinical Microbiology, 2003
- Evidence for a Continuum of Decreased Vancomycin Susceptibility in UnselectedStaphylococcus aureusClinical IsolatesThe Journal of Infectious Diseases, 2002
- Vancomycin-Intermediate and -Resistant Staphylococcus aureus: What the Infectious Disease Specialist Needs to KnowClinical Infectious Diseases, 2001
- Impact of theagrQuorum‐Sensing System on Adherence to Polystyrene inStaphylococcus aureusThe Journal of Infectious Diseases, 2000